Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$0.16 - $100.0 $9,191 - $5.74 Million
57,449 New
57,449 $9,000
Q2 2022

Aug 15, 2022

SELL
$0.2 - $0.5 $5,451 - $13,627
-27,255 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$0.41 - $0.63 $5,316 - $8,168
12,966 Added 90.74%
27,255 $15,000
Q4 2021

Feb 14, 2022

BUY
$0.57 - $1.29 $2,490 - $5,636
4,369 Added 44.04%
14,289 $8,000
Q3 2021

Nov 15, 2021

BUY
$1.11 - $1.7 $6,430 - $9,848
5,793 Added 140.37%
9,920 $12,000
Q2 2021

Aug 16, 2021

BUY
$1.46 - $2.25 $743 - $1,145
509 Added 14.07%
4,127 $7,000
Q1 2021

May 17, 2021

SELL
$1.77 - $2.93 $7,172 - $11,872
-4,052 Reduced 52.83%
3,618 $6,000
Q4 2020

Feb 16, 2021

BUY
$2.13 - $3.26 $607 - $929
285 Added 3.86%
7,670 $16,000
Q3 2020

Nov 16, 2020

SELL
$1.53 - $3.13 $30,918 - $63,251
-20,208 Reduced 73.24%
7,385 $22,000
Q2 2020

Aug 13, 2020

BUY
$0.48 - $1.75 $5,580 - $20,345
11,626 Added 72.81%
27,593 $41,000
Q1 2020

May 15, 2020

BUY
$0.56 - $0.97 $8,941 - $15,487
15,967 New
15,967 $9,000
Q4 2019

Feb 07, 2020

SELL
$0.62 - $1.06 $8,033 - $13,734
-12,957 Closed
0 $0
Q3 2019

Nov 05, 2019

BUY
$0.81 - $1.06 $2,652 - $3,471
3,275 Added 33.83%
12,957 $13,000
Q2 2019

Aug 13, 2019

BUY
$0.94 - $1.6 $8,913 - $15,171
9,482 Added 4741.0%
9,682 $10,000
Q1 2019

May 14, 2019

SELL
$0.51 - $1.88 $3,696 - $13,626
-7,248 Reduced 97.31%
200 $0
Q4 2018

Feb 14, 2019

BUY
$0.39 - $3.47 $1,513 - $13,467
3,881 Added 108.8%
7,448 $3,000
Q3 2018

Nov 13, 2018

BUY
$1.39 - $2.25 $4,958 - $8,025
3,567 New
3,567 $8,000
Q2 2018

Aug 15, 2018

SELL
$1.44 - $2.24 $5,447 - $8,473
-3,783 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$1.51 - $2.06 $2,479 - $3,382
1,642 Added 76.69%
3,783 $6,000
Q4 2017

Feb 09, 2018

SELL
$1.4 - $2.6 $13,655 - $25,360
-9,754 Reduced 82.0%
2,141 $3,000
Q3 2017

Nov 14, 2017

BUY
$2.22 - $2.79 $26,406 - $33,187
11,895
11,895 $30,000

About TREVENA INC


  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $273M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.